Filing Details

Accession Number:
0001181431-11-009280
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-10 21:55:55
Reporting Period:
2011-02-10
Filing Date:
2011-02-10
Accepted Time:
2011-02-10 21:55:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306695 Sanderling Venture Partners Vi Co Investment Fund Lp C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1306717 Sanderling Venture Partners Vi Lp C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429282 Partnership Limited Vi Sanderling C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429283 Sanderling Vi Beteiligungs Gmbh & Co Kg C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429588 Vi Management Ventures Sanderling C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-08 27,931 $7.00 27,931 No 4 P Direct
Common Stock Acquisiton 2011-02-08 4,297 $7.00 4,297 No 4 P Direct
Common Stock Acquisiton 2011-02-08 5,119 $7.00 5,119 No 4 P Direct
Common Stock Acquisiton 2011-02-08 184,131 $7.00 184,131 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The securities are held by Sanderling Ventures Management VI.
  2. The securities are held by Sanderling VI Beteiligungs GmbH & Co. KG.
  3. The securities are held by Sanderling VI Limited Partnership.
  4. The securities are held by Sanderling Venture Partners VI Co-Investment Fund.